U.S. market Closed. Opens in 11 hours 59 minutes

COGT | Cogent Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/A7.87M22.50M9.73M8.36M6.36M2.99M
Cost of Revenue3.59M5.88M147.00K25.74K43.71KN/AN/AN/AN/A
Gross Profit-3.59M-5.88M-147.00K7.85M22.46M9.73MN/AN/AN/A
Operating Expenses204.54M147.84M75.55M90.07M54.68M45.74M34.51MN/AN/A
Selling, General & Admin34.38M26.21M19.64M17.42M10.97M7.45M4.68M3.43M2.73M
Research & Development170.17M121.63M55.91M72.65M43.71M38.28M29.83M21.99M6.85M
Other Operating ExpensesN/A3.61M2.81M-246.00K78.00K320.00KN/AN/AN/A
Operating Income-208.13M-147.84M-75.55M-82.20M-32.18M-36.01M-26.15M-19.07M-6.59M
Other Expenses / Income15.72M7.60M3.28M7.39M345.00K320.00K660.00K946.00KN/A
Before Tax Income-192.41M-140.24M-72.27M-74.81M-31.83M-34.53M-25.49M-18.12M-6.59M
Income Tax ExpensesN/A-7.60M-467.00K-8.36M-1.56M1.47MN/AN/AN/A
Net Income-192.41M-132.64M-71.81M-66.45M-30.27M-34.53M-25.49M-18.12M-6.59M
Interest ExpensesN/A3.99MN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding79.66M58.74M38.73M11.08M7.62M6.22M5.86M5.86M5.86M
Diluted Shares Outstanding79.66M58.74M38.73M11.08M7.62M6.22M5.86M7.40M7.40M
EBITDA-204.54M-147.84M-75.40M-89.69M-32.18M-34.68M-24.32M-17.29M-6.41M
EBITDA Margin0.00%0.00%0.00%-1,139.52%-143.02%-356.32%-290.92%-272.13%-214.77%
EBIT-192.41M-136.25M-72.27M-74.81M-31.83M-33.06M-25.49M-18.12M-6.59M
EBIT Margin0.00%0.00%0.00%-950.43%-141.49%-339.62%-304.93%-285.19%-220.76%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙